Law Firm Investigation Casts Spotlight on Travere Therapeutics’ Disclosures—What Should Investors Watch Next?
Market Chameleon (Fri, 16-Jan 11:22 AM)
Travere Therapeutics Expects Record $410M in 2025 U.S. Sales on FILSPARI Surge and Eyes Key 2026 Milestones
Market Chameleon (Tue, 13-Jan 7:05 AM)
